Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Last Updated: August 19, 2022

Solopak Company Profile

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

What is the competitive landscape for SOLOPAK, and what generic and branded alternatives to SOLOPAK drugs are available?

SOLOPAK has thirty-three approved drugs.

Summary for Solopak

US Patents:	0
Tradenames:	16
Ingredients:	15
NDAs:	33

Drugs and US Patents for Solopak

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try it Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Solopak	KANAMYCIN SULFATE	kanamycin sulfate	INJECTABLE;INJECTION	062605-003	Feb 26, 1986		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
Solopak	HYDROXYZINE HYDROCHLORIDE	hydroxyzine hydrochloride	INJECTABLE;INJECTION	087591-001	Approved Prior to Jan 1, 1982		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
Solopak	HEPARIN LOCK FLUSH	heparin sodium	INJECTABLE;INJECTION	087903-001	Apr 20, 1983		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
Solopak	HEPARIN LOCK FLUSH	heparin sodium	INJECTABLE;INJECTION	087905-001	Apr 20, 1983		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
Solopak	PHENYTOIN SODIUM	phenytoin sodium	INJECTABLE;INJECTION	088520-001	Dec 17, 1984		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
Solopak	HYDROXYZINE HYDROCHLORIDE	hydroxyzine hydrochloride	INJECTABLE;INJECTION	086822-001	Approved Prior to Jan 1, 1982		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Solopak

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck

Colorcon

Moodys

Dow

Express Scripts

AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.